News

Filter

Current filters:

None

276 to 285 of 97249 results

Spanish physicians’ understanding of biosimilars: ASBM survey

28-11-2014

The Alliance for Safe Biologic Medicines (ASMB) presented results from a survey of European physicians…

BiosimilarsBiotechnologyHealthcareMarkets & MarketingSpain

Cocrystal Pharma and RFS Pharma complete merger

28-11-2014

USA-based biotech firm Cocrystal Pharma has announced the closing of its merger with RFS Pharma, a privately…

Anti-viralsBiotechnologyCocrystal PharmaMergers & AcquisitionsRFS Pharma

Global oncology biosimilars market 2014-2018

28-11-2014

The global oncology biosimilars market is expected to expand at a compound annual growth rate (CAGR)…

BioconBiosimilarsCellTrionDr Reddy's LaboratoriesGenericsGlobalHospiraMarkets & MarketingMylanSandoz

Teva appoints Yitzhak Peterburg as chairman of the board

Teva appoints Yitzhak Peterburg as chairman of the board

27-11-2014

Israel-based Teva Pharmaceuticals has appointed Yitzhak Peterburg as chairman of the board of directors.

BoardroomIsraelPharmaceuticalTevaTeva Pharmaceuticals

A back-to-biology approach to cancer therapies: an interview with Berg's Dr Niven Narain

A back-to-biology approach to cancer therapies: an interview with Berg's Dr Niven Narain

27-11-2014

Massachusetts-based biopharma company Berg is aiming to change the way we treat cancer.

BergBiotechnologyOncologyResearchUSA

NICE final draft guidance recommends Soliris, but saying it is “very expensive”

NICE final draft guidance recommends Soliris, but saying it is “very expensive”

27-11-2014

The UK National Institute for Health and Care Excellence (NICE) has today issued final draft guidance…

Alexion PharmaceuticalsBiotechnologyPricingRare diseasesRegulationSolirisUK

Japan’s Takeda optimizes global production network

27-11-2014

Takeda Pharmaceutical has decided to focus its Osaka plant (Osaka Prefecture, Japan) to become a specialty…

GermanyJapanLupronOncologyPharmaceuticalProductionTakeda Pharmaceutical

UK uses fewer branded medicines per person than comparable countries and is still using older therapies

UK uses fewer branded medicines per person than comparable countries and is still using older therapies

27-11-2014

The Association of the British Pharmaceutical Industry has published new research showing that UK use…

ABPIMarkets & MarketingPharmaceuticalRegulationUK

276 to 285 of 97249 results

Back to top